Fortunellin ameliorates LPS ‐induced acute lung injury, inflammation, and collagen deposition by restraining the TLR4/NF‐κB/NLRP3 pathway

ConclusionFortunellin attenuated LPS-stimulated ALI through repressing the TLR4/NF- κB/NLRP3 pathway. Fortunellin may be a valuable drug for ALI therapy.

Source: Immunity, Inflammation and Disease - March 19, 2024 Category: Allergy & Immunology Authors: Danjuan Liu, Rongjie Guo, Bingbing Shi, Min Chen, Shuoyun Weng, Junting Weng Tags: ORIGINAL ARTICLE Source Type: research